[Neonatal outcome of fetal hyperechogenic bowel].


OBJECTIVE Echogenic bowel (EB) represents 1 % of pregnancy and is a risk factor of fetal pathology (infection, cystic fibrosis, aneuploidy). The aim of our study was to determine the fetuses' outcomes with isolated EB. PATIENTS AND METHODS This is a retrospective study of all patients who presented singleton gestations with a fetal isolated echogenic bowel between 2004 and 2011 in two prenatal diagnosis centers. Search of aneuploidy, infection and cystic fibrosis was systematically proposed as well as an ultrasound monitoring. RESULTS On 109 fetus addressed for isolate echogenic bowel five had other signs associated and 74 had a real isolated echogenic bowel (without dilatation, calcification, intrauterine growth restriction). In 30 cases, the EB was not found. Eighty-five percent of the patients had in the first trimester a screening for trisomy 21. None fetus with isolated EB had trisomy, infection or cystic fibrosis. One fetus died in utero and one newborn died of a metabolic disease without digestive repercussions. DISCUSSION AND CONCLUSION The risk of trisomy 21 and the risk to have a serious disease appear low for the fetus with EB. It does not seem necessary to propose a systematic amniocentesis in case of isolated echogenic bowel.

DOI: 10.1016/j.gyobfe.2014.01.006

Cite this paper

@article{Maillet2014NeonatalOO, title={[Neonatal outcome of fetal hyperechogenic bowel].}, author={Laurent Maillet and R C Rudigoz and Rachel Buffin and J{\'e}r{\^o}me Massardier and Pascal Gaucherand and Cyril Huissoud}, journal={Gynecologie, obstetrique & fertilite}, year={2014}, volume={42 6}, pages={383-6} }